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populations, which is a common 
application of conventional 
playback technology 
experiments.
They found that owls were 
equally responsive to sounds 
played by mobile phone to 
those broadcast from a CD via 
conventional equipment. In 11 
out of 18 trials using mobile 
phone sounds owls responded, 
compared with 10 out of 18 trials 
with conventional techniques.
The researchers then looked 
further at the nine locations 
where owls responded to both 
sources of sound. They found no 
difference in the response time 
of the birds to both sources of 
sound.
“Our data demonstrate that 
cellular telephony is a viable 
method of remote playback for 
certain applications,” the authors 
write. But they do caution about 
the range of sounds that can 
be transmitted and recorded. 
The phone systems have been 
optimized for the perception 
of humans which may create 
problems with higher frequency 
sounds used by other species.
Dialled up: New research has discovered that sounds emitted by mobile phones 
could be recognised by owls (Barred owl (Strix varia), here) and their responses 
recorded too. (Photograph: © David Hosking/Alamy).Q & A
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What turned you on to biology 
in the first place? In high 
school I thought biology and 
chemistry were old fashioned 
and boring areas of study. I 
loved mathematics and music, 
yet because of a lack of talent a 
career as a musician was out of 
reach. So eventually I decided to 
study medicine at the University 
of Munich. I developed some 
passion for cardiology and 
radiology and wondered whether 
I should go into clinical medicine, 
but I also loved the biochemistry 
courses. I was impressed that 
the soon- to- retire director of 
the institute, Theodor Bücher, 
a student of Otto Warburg, 
personally taught the practical 
biochemical course to medical 
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R821students. This was in the late 
1970s when Günter Blobel 
and Bernhard Dobberstein 
had developed the concept 
of co-translational protein 
targeting to the endoplasmic 
reticulum, while Walter Neupert 
and Gottfried Schatz had 
established the concept of 
post- translational protein 
transport into mitochondria. Thus, 
two apparently conflicting models 
for the mechanism of protein 
sorting in a cell were emerging. 
When Walter Neupert, a student 
of Theodor Bücher, came back 
to Munich in the early 1980s, I 
thought that protein sorting might 
be an interesting topic for a test 
year in basic research and asked 
Walter Neupert if he would take an 
MD. To my delight and surprise, 
he agreed and I studied the role 
of the mitochondrial membrane 
potential in protein biogenesis. 
Why did you stay in basic 
research and not become a 
physician? After one year in the 
lab, one of the senior professors 
of the institute took me aside 
and told me that there was no 
future in biochemistry and I would 
most likely be an unemployed 
scientist if I continued a career in 
pure research. He recommended 
that I pursue clinical work so 
that I would have a stable career 
and income. Having two young 
children I was a bit shocked by 
his advice, but I had just made 
an unexpected finding that did 
not fit into the model of protein 
transport into mitochondria at 
that time. The prevailing model 
stated that protein translocation 
across both mitochondrial 
membranes occurred at sites of 
stable contact between outer 
and inner membranes and thus, 
transport across both membranes 
had to be tightly coupled. I 
observed a transport intermediate 
that seemed to have passed 
the outer membrane but was 
not yet integrated into the inner 
membrane, suggesting a separate 
translocation across both 
membranes. As it was assumed 
that each cellular organelle 
possessed only one mechanism 
of protein import, my results did 
not fit at all. Other lab members 
told me that my experiments were likely artefacts and that I should 
disregard them. This situation 
raised my interest even more and 
I wanted to solve the problem. 
The experiments eventually 
revealed a new mechanism of 
sequential protein translocation 
across two membranes (now 
known as the carrier pathway) 
and showed that there is not one 
uniform mechanism of transport 
into a cell organelle, but diverse 
import pathways mediating the 
integration of diverse precursor 
proteins. 
From thereon, I never thought 
about practical medicine 
anymore, but was so excited 
by the questions of molecular 
cell research that I stayed in 
basic research. It was important 
that the laboratory of Walter 
Neupert had a very open and 
stimulating atmosphere. He 
gave his co- workers a lot of 
independence to study novel 
questions and develop their own 
concepts. I remember many 
passionate discussions with Ulrich 
Hartl. Ulrich and I often spent 
whole days just discussing new 
experiments and hypotheses 
about protein translocation and 
molecular chaperones. 
Are scientific controversies 
helpful? Short answer: yes. 
Long answer: controversies are 
important stimuli for scientific 
dialogues and for the development 
of experimental approaches, 
as long as the discussions 
stay on a scientific level. Often 
controversies start with two 
seemingly contradictory views but 
end up with the insight that nature 
is more flexible and versatile than 
we had expected — the solution 
to a problem often encompasses 
elements of both opposing 
hypotheses or a third hypothesis 
turns out to provide the answer. 
In controversial discussions, 
sometimes many theoretical 
arguments are collected to 
argue that a mechanism or 
pathway cannot exist, but 
biology likes to surprise us and 
most (hotly debated) predictions 
that something cannot exist 
were proven wrong. Actually, 
scientific controversies are not 
only stimulating to the scientists 
involved (and the audience at meetings) but also to editors of 
journals who like to present the 
different views on a topic.
What do you think of 
high- throughput studies?  
I followed the development and 
impact of high-throughput studies 
from their beginning with the 
model organism baker’s yeast, 
the first eukaryote whose genome 
was completely sequenced 
and where a comprehensive 
collection of mutants was 
generated by the concerted 
effort of numerous colleagues 
from the yeast community. The 
genomic and proteomic studies 
with yeast had a major impact 
on our studies. Before we knew 
about the complete genome, it 
was very laborious, and could take 
several years, to clone a gene of 
interest or to identify the protein 
that belonged to a potentially 
interesting band on a gel. Together 
with mass spectrometry, it is now 
exciting how quickly you can get 
your gene or protein of interest. 
But high-throughput studies lack 
the rigorous controls and detailed 
knowledge of the properties 
and pitfalls of individual genes 
or proteins that we obtain from 
focussed studies. Thus, errors and 
mistakes are orders of magnitudes 
more frequent and the databases 
fill up with less controlled data. It is 
thus critical to see high-throughput 
studies as screening studies that 
reveal potentially interesting results 
but usually do not prove their 
biological significance. 
When you see an interesting 
outcome of a high-throughput 
study that impacts your own 
research, do not simply believe 
it but go back to detailed 
biochemical and genetic studies 
and verify the findings in your own 
lab. For example, the localization 
of proteins in a cell by tagging 
approaches, such as attachment 
of the green fluorescent protein, is 
commonly used, but the targeting 
of many proteins can be influenced 
by the tag, so that the proteins end 
up in the wrong compartment, for 
example, they may end up in the 
endoplasmic reticulum instead of 
mitochondria or stay in the cytosol 
because the tag interferes with 
translocation across a membrane. 
So high-throughput studies are 
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Quick guide
Blindsight
Petra Stoerig1 and Alan Cowey2
What is blindsight? The visual 
functions that can be elicited in 
response to stimuli presented 
within fields of cortical blindness 
have become known as blindsight. 
The ‘blind’ in blindsight reflects 
the patients’ claims not to see 
the stimuli at all, while the ‘sight’ 
refers to their residual or recovered 
ability to localize, detect and 
discriminate between such unseen 
stimuli. This divorce between 
blindness and visual performance 
is captured in the term blindsight 
coined by Lawrence Weiskrantz 
and colleagues in 1974, and 
makes the phenomenon intriguing 
to psychologists, cognitive 
neuroscientists, and philosophers. 
How is it studied? The ‘direct’ 
approaches get around the 
‘invisibility’ of blind field stimuli 
by asking the patients to guess 
whether, where or which one of 
a small number of stimuli has 
been presented within the blind 
field. Prompted by consciously 
accessible auditory or visual stimuli, 
the patients are ‘forced’ to reach 
for, to initiate eye movements to, 
or to press different buttons for 
different blind-field targets. The 
alternative ‘indirect’ approach does 
not require that patients respond 
to ‘unseen’ targets, but engages 
them in responding to target stimuli 
presented to their sighted field. By 
presenting additional blind- field 
stimuli, the experimenter learns 
whether these modulate the 
responses to the visible stimuli.
Most commonly, reaction times to 
the consciously accessible stimuli 
are measured, but perceptual 
influences of stimuli in the blind 
field on targets presented to 
the sighted field have also been 
assessed.
Both forced-choice and indirect 
methods require many trials for 
evaluation, and the same is true 
for psychophysiological responses 
that include galvanic skin and 
pupil responses which can also be important for screening purposes, 
but have to be combined with 
detailed biochemical and 
functional studies. In fact, the 
experience with yeast showed that 
the many possibilities offered by 
genomics and proteomics shifted 
the emphasis from cloning back 
to biochemistry and thus gave us 
more time for functional studies.
What is the biggest hindrance 
to science? Administrators 
who like paragraphs more than 
science, and politicians who think 
that science is only possible in 
large consortia and on topics that 
have been decided by committees 
beforehand. There is no doubt 
that large centres are important, 
in particular for stimulation of 
interdisciplinary discussion, for 
high-throughput studies and the 
use of expensive equipment. But 
we should not forget that most 
pioneering findings in biology 
have been made by individuals 
or small groups of scientists who 
were just driven by their scientific 
curiosity and not by large 
frameworks or programs. The 
individual freedom and flexibility 
of a scientist are the biggest value 
in science and we should never 
trade them off for short-term 
benefits or political purposes. 
When is it time to move to a 
new field of research? The 
personal answer is when you lose 
excitement about your work and 
don’t think about your project 
day and night then it may be time 
to look for a new challenge. The 
scientific answer is that when 
the major questions in a field are 
solved you should go on to a 
new area. But the problem is to 
know when the major questions 
are solved. For example, in 2001 
the various groups working on 
mitochondrial biogenesis thought 
that we had solved the major 
questions, having identified the 
main components of the two 
protein import pathways and thus 
we started to think about what’s 
next. Soon after, the field nearly 
exploded and we found two new 
protein import pathways with 
novel mechanisms of targeting 
and protein assembly and doubled 
the number of crucial import 
components. The reason for this boost was a combination of 
native techniques for analysis of 
protein complexes and transport 
intermediates, as well as the 
outcome of a comprehensive 
proteomic characterization of 
mitochondria that revealed many 
essential proteins with previously 
unknown function. Thus, in 2001 
we had thought we understood 
mitochondrial biogenesis, now we 
know that we had missed at least 
half of the story.
What are the future challenges 
in molecular cell biology? The 
hottest stories often develop 
from surprising side effects and 
putative artefacts of experiments. 
One needs an open eye to 
distinguish those so-called 
artefacts that turn out to be 
exciting new findings. I think 
that the dynamic organization 
of cells and the cross-talk of 
cellular compartments will be 
major questions to be solved 
on a molecular level. Proteins 
and protein complexes do not 
function as separate entities but 
are functionally and physically 
integrated into large networks 
that are regulated in space and 
time. Because the interactions 
are often weak or transient in 
nature, we need in vivo analyses 
of supramolecular complexes 
and mild conditions to open 
cells in order to preserve these 
higher- order structures. The 
cytosol is not simply a ‘soup’ 
where molecules diffuse but likely 
a highly organized compartment 
that channels the trafficking 
of molecules. And many more 
proteins than we know so far 
will have two or more different 
functions and subcellular 
localizations. We will need input 
from various sides, large-scale 
omics-studies, single molecule 
studies, as well as detailed 
biochemical and cell biological 
analysis to understand the 
complexity of cellular organization 
and its regulation — and be 
prepared for the unexpected.
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